Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
NVIDIA Corp ha un obiettivo di prezzo consensuale di $212.29, basato sulle valutazioni degli ultimi 35 analisti. Il massimo è $250 emesso da Keybanc il settembre 30, 2025, mentre il minimo è $100 emesso da Seaport Global il aprile 30, 2025. Le ultime 3 valutazioni degli analisti sono state pubblicate da Keybanc, Citigroup e Jefferies il settembre 30, 2025, settembre 30, 2025 e settembre 29, 2025. Con un obiettivo di prezzo medio di $226.67 tra Keybanc, Citigroup e Jefferies, c'è un cambiamento implicito del 19.35% upside per NVIDIA Corp secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
09/30/2025 | 31.64% | Keybanc | $230 → $250 | Maintains | Overweight | |||
09/30/2025 | 10.58% | Citigroup | $200 → $210 | Maintains | Buy | |||
09/29/2025 | 15.84% | Jefferies | — | $205 → $220 | Maintains | Buy | ||
09/25/2025 | 26.38% | Barclays | $200 → $240 | Maintains | Overweight | |||
09/23/2025 | 10.58% | DA Davidson | $210 → $210 | Maintains | Buy | |||
09/23/2025 | 18.48% | Evercore ISI Group | $214 → $225 | Maintains | Outperform | |||
09/23/2025 | 13.21% | Rosenblatt | $215 → $215 | Maintains | Buy | |||
09/11/2025 | 10.58% | DA Davidson | $195 → $210 | Upgrade | Neutral → Buy | |||
09/08/2025 | 5.31% | Citigroup | $210 → $200 | Maintains | Buy | |||
09/04/2025 | 13.21% | JP Morgan | $215 → $215 | Maintains | Overweight | |||
08/28/2025 | 10.58% | Citigroup | $190 → $210 | Maintains | Buy | |||
08/28/2025 | 13.21% | JP Morgan | $170 → $215 | Maintains | Overweight | |||
08/28/2025 | 2.68% | DA Davidson | $135 → $195 | Maintains | Neutral | |||
08/28/2025 | 5.31% | Goldman Sachs | $200 → $200 | Reiterates | Buy → Buy | |||
08/28/2025 | 29.01% | Craig-Hallum | $195 → $245 | Maintains | Buy | |||
08/28/2025 | 18.48% | Oppenheimer | $200 → $225 | Maintains | Outperform | |||
08/28/2025 | 10.58% | Morgan Stanley | $206 → $210 | Maintains | Overweight | |||
08/28/2025 | 23.74% | B of A Securities | $220 → $235 | Maintains | Buy | |||
08/28/2025 | 10.58% | Wedbush | $210 → $210 | Reiterates | Outperform → Outperform | |||
08/28/2025 | 20.06% | Truist Securities | $210 → $228 | Maintains | Buy | |||
08/28/2025 | 26.38% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
08/28/2025 | 21.11% | Keybanc | $215 → $230 | Maintains | Overweight | |||
08/28/2025 | 18.48% | Bernstein | $185 → $225 | Maintains | Outperform | |||
08/28/2025 | 13.21% | Rosenblatt | $200 → $215 | Maintains | Buy | |||
08/28/2025 | 15.84% | Benchmark | $190 → $220 | Maintains | Buy | |||
08/28/2025 | 5.31% | Needham | $200 → $200 | Reiterates | Buy → Buy | |||
08/25/2025 | 11.63% | Stifel | $202 → $212 | Maintains | Buy | |||
08/25/2025 | 18.48% | Baird | $195 → $225 | Maintains | Outperform | |||
08/22/2025 | 12.68% | Evercore ISI Group | $190 → $214 | Maintains | Outperform | |||
08/21/2025 | 7.95% | UBS | $175 → $205 | Maintains | Buy | |||
08/21/2025 | 10.58% | Wedbush | $175 → $210 | Maintains | Outperform | |||
08/20/2025 | 13.21% | Keybanc | $190 → $215 | Maintains | Overweight | |||
08/19/2025 | 23.74% | TD Cowen | $140 → $235 | Maintains | Buy | |||
08/18/2025 | 26.38% | Cantor Fitzgerald | $200 → $240 | Maintains | Overweight | |||
08/18/2025 | 8.47% | Morgan Stanley | $200 → $206 | Maintains | Overweight | |||
08/14/2025 | 7.95% | Mizuho | $192 → $205 | Maintains | Outperform | |||
08/13/2025 | 18.48% | Piper Sandler | $180 → $225 | Maintains | Overweight | |||
08/11/2025 | 15.84% | Wells Fargo | $185 → $220 | Maintains | Overweight | |||
08/07/2025 | 5.31% | Goldman Sachs | $185 → $200 | Maintains | Buy | |||
08/04/2025 | 15.84% | B of A Securities | $220 → $220 | Reiterates | Buy → Buy | |||
07/30/2025 | 5.31% | Morgan Stanley | $170 → $200 | Maintains | Overweight | |||
07/16/2025 | 1.1% | Mizuho | $185 → $192 | Maintains | Outperform | |||
07/16/2025 | 5.31% | Needham | $160 → $200 | Maintains | Buy | |||
07/15/2025 | 15.84% | B of A Securities | $180 → $220 | Maintains | Buy | |||
07/15/2025 | 2.68% | DZ Bank | $160 → $195 | Maintains | Buy | |||
07/15/2025 | 23.74% | Melius Research | $205 → $235 | Maintains | Buy | |||
07/15/2025 | 5.31% | Oppenheimer | $175 → $200 | Maintains | Outperform | |||
07/10/2025 | -2.59% | Goldman Sachs | → $185 | Initiates | → Buy | |||
07/07/2025 | 0.05% | Citigroup | $180 → $190 | Maintains | Buy | |||
07/03/2025 | -2.59% | Mizuho | $170 → $185 | Maintains | Outperform | |||
06/25/2025 | 31.64% | Loop Capital | $175 → $250 | Maintains | Buy | |||
06/17/2025 | 5.31% | Barclays | $170 → $200 | Maintains | Overweight | |||
06/16/2025 | -7.85% | Oppenheimer | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/29/2025 | -5.22% | B of A Securities | $160 → $180 | Maintains | Buy | |||
05/29/2025 | 10.58% | Truist Securities | $205 → $210 | Maintains | Buy | |||
05/29/2025 | -13.12% | Raymond James | $150 → $165 | Maintains | Strong Buy | |||
05/29/2025 | -5.22% | Piper Sandler | $150 → $180 | Maintains | Overweight | |||
05/29/2025 | -10.48% | Mizuho | $168 → $170 | Maintains | Outperform | |||
05/29/2025 | -5.22% | Citigroup | $150 → $180 | Maintains | Buy | |||
05/29/2025 | -10.48% | Morgan Stanley | $160 → $170 | Maintains | Overweight | |||
05/29/2025 | -10.48% | Barclays | $155 → $170 | Maintains | Overweight | |||
05/29/2025 | -28.91% | DA Davidson | $120 → $135 | Maintains | Neutral | |||
05/29/2025 | 5.31% | Rosenblatt | $178 → $200 | Maintains | Buy | |||
05/29/2025 | 0.05% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
05/29/2025 | -15.75% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
05/22/2025 | -7.85% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/14/2025 | -15.75% | B of A Securities | $150 → $160 | Maintains | Buy | |||
05/12/2025 | -7.85% | UBS | $180 → $175 | Maintains | Buy | |||
04/30/2025 | -47.34% | Seaport Global | → $100 | Initiates | → Sell | |||
04/25/2025 | -15.75% | Morgan Stanley | $162 → $160 | Maintains | Overweight | |||
04/23/2025 | -6.27% | Rosenblatt | $200 → $178 | Maintains | Buy | |||
04/22/2025 | -18.38% | Barclays | $175 → $155 | Maintains | Overweight | |||
04/17/2025 | -5.22% | UBS | $185 → $180 | Maintains | Buy | |||
04/16/2025 | 0.05% | Evercore ISI Group | $190 → $190 | Reiterates | Outperform → Outperform | |||
04/16/2025 | 5.31% | Rosenblatt | $220 → $200 | Maintains | Buy | |||
04/16/2025 | -36.81% | DA Davidson | $120 → $120 | Maintains | Neutral | |||
04/16/2025 | -21.02% | Raymond James | $170 → $150 | Maintains | Strong Buy | |||
04/16/2025 | 5.31% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -21.02% | Piper Sandler | $175 → $150 | Maintains | Overweight | |||
04/16/2025 | -7.85% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -15.75% | B of A Securities | $200 → $160 | Maintains | Buy | |||
04/14/2025 | -36.81% | DA Davidson | $125 → $120 | Maintains | Neutral | |||
04/11/2025 | -21.02% | Citigroup | $163 → $150 | Maintains | Buy | |||
04/09/2025 | -26.28% | TD Cowen | $175 → $140 | Maintains | Buy | |||
03/20/2025 | -34.18% | DA Davidson | $135 → $125 | Maintains | Neutral | |||
03/20/2025 | 0.05% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/19/2025 | -5.22% | Susquehanna | $180 → $180 | Maintains | Positive | |||
03/19/2025 | 5.31% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
03/19/2025 | — | Keybanc | — | Reiterates | Overweight → Overweight | |||
03/19/2025 | 5.31% | B of A Securities | $200 → $200 | Reiterates | Buy → Buy | |||
03/19/2025 | -15.75% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
03/19/2025 | 15.84% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
03/19/2025 | 0.05% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/14/2025 | -11.54% | Mizuho | $175 → $168 | Maintains | Outperform | |||
02/27/2025 | -28.91% | DA Davidson | $135 → $135 | Maintains | Neutral | |||
02/27/2025 | 5.31% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
02/27/2025 | 0.05% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
02/27/2025 | 7.95% | Truist Securities | $204 → $205 | Maintains | Buy | |||
02/27/2025 | -14.7% | Morgan Stanley | $152 → $162 | Maintains | Overweight | |||
02/27/2025 | 5.31% | B of A Securities | $190 → $200 | Maintains | Buy |
L'ultimo obiettivo di prezzo per NVIDIA (NASDAQ:NVDA) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $250.00 prevedendo che NVDA raggiunga rise entro 12 mesi (un possibile 31.64% upside).
L'ultima valutazione degli analisti per NVIDIA (NASDAQ:NVDA) è stato fornita da Keybanc e NVIDIA mantenuto il suo rating overweight.
L'ultima revisione al rialzo di NVIDIA Corp è avvenuta il settembre 11, 2025, quando DA Davidson ha alzato il suo obiettivo di prezzo a $210. In precedenza DA Davidson aveva a neutral per NVIDIA Corp.
Non esiste una revisione finale al ribasso per NVIDIA.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di NVIDIA e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di NVIDIA è stata depositata il settembre 30, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a settembre 30, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di NVIDIA (NVDA) è stata una mantenuto con un obiettivo di prezzo di $230.00 a $250.00. Il prezzo attuale a cui NVIDIA (NVDA) è scambiato è $189.91, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.